Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: rkrw who wrote (4022)	6/6/2001 9:39:03 AM
From: Michael Young	Read Replies (1) \| Respond to of 52153

Let's put this entire Cramer thing to rest, as it is boring everyone to death. My understanding is that the firm was up substantially last year, mainly because they played the short side in tech. I don't think Cramer is any kind of biotech genius, not in the least. Most of the people on this thread know much more about these stocks than he ever will. I just like that he has said he wants to substantially increase thestreet.com's focus on biotechs. I think that is a good thing. Some people get pissed because they do negative stories on some biotechs. But that gives an insight into what the healthcare hedge funds are thinking, and counterbalances the incessant cheerleading from most analysts. MIKE